Scientists test two pill versions of cancer drug in advanced tumor patients

NCT ID NCT00777582

First seen Jan 15, 2026 · Last updated May 15, 2026 · Updated 22 times

Summary

This study compares how well the body absorbs two different pill forms of the experimental drug AZD2281 in people with advanced solid tumors that no longer respond to standard treatments. About 197 participants will receive both forms in a random order to measure drug levels and safety. The goal is to find out if a new tablet works as well as the current capsule, without aiming to cure the disease.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SOLID TUMORS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Research Site

    Randwick, 2031, Australia

  • Research Site

    Leuven, 3000, Belgium

  • Research Site

    Bellinzona, CH-6500, Switzerland

  • Research Site

    Edinburgh, EH4 2XR, United Kingdom

  • Research Site

    London, NW1 2PG, United Kingdom

  • Research Site

    Manchester, M20 4BX, United Kingdom

  • Research Site

    Newcastle upon Tyne, NE7 7DN, United Kingdom

  • Research Site

    Northwood, HA6 2RN, United Kingdom

  • Research Site

    Oxford, OX3 7LE, United Kingdom

  • Research Site

    Sutton, SM2 5PT, United Kingdom

Conditions

Explore the condition pages connected to this study.